These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease. da Silva CP; de M Abreu G; Cabello Acero PH; Campos M; Pereira JS; de A Ramos SR; Nascimento CM; Voigt DD; Rosso AL; Araujo Leite MA; Vasconcellos LFR; Nicaretta DH; Della Coletta MV; da Silva DJ; Gonçalves AP; Dos Santos JM; Calassara V; Valença DCT; de M Martins CJ; Santos-Rebouças CB; Pimentel MMG J Neurol Sci; 2017 Oct; 381():160-164. PubMed ID: 28991672 [TBL] [Abstract][Full Text] [Related]
13. Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers. Pachi I; Koros C; Simitsi AM; Papadimitriou D; Bougea A; Prentakis A; Papagiannakis N; Bozi M; Antonelou R; Angelopoulou E; Beratis I; Stamelou M; Trapali XG; Papageorgiou SG; Stefanis L Parkinsonism Relat Disord; 2021 Oct; 91():1-8. PubMed ID: 34425330 [TBL] [Abstract][Full Text] [Related]
14. Left corticospinal tract could be a biomarker to identify the dual prodromal LRRK2/GBA mutated Parkinson's disease. Lin F; Ruan X; Zou X; Weng H; Zeng Y; Zheng J; Ye Q; Meng F; Chen X; Cai G CNS Neurosci Ther; 2024 Jun; 30(6):e14728. PubMed ID: 38837664 [TBL] [Abstract][Full Text] [Related]
15. Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genes. Thaler A; Kozlovski T; Gurevich T; Bar-Shira A; Gana-Weisz M; Orr-Urtreger A; Giladi N; Mirelman A Mov Disord; 2018 Oct; 33(10):1656-1660. PubMed ID: 30288804 [TBL] [Abstract][Full Text] [Related]
16. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366 [TBL] [Abstract][Full Text] [Related]
17. A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease. Omer N; Giladi N; Gurevich T; Bar-Shira A; Gana-Weisz M; Goldstein O; Kestenbaum M; Cedarbaum JM; Orr-Urtreger A; Mirelman A; Thaler A Mov Disord; 2020 Jul; 35(7):1249-1253. PubMed ID: 32353202 [TBL] [Abstract][Full Text] [Related]
18. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression. Ortega RA; Wang C; Raymond D; Bryant N; Scherzer CR; Thaler A; Alcalay RN; West AB; Mirelman A; Kuras Y; Marder KS; Giladi N; Ozelius LJ; Bressman SB; Saunders-Pullman R JAMA Netw Open; 2021 Apr; 4(4):e215845. PubMed ID: 33881531 [TBL] [Abstract][Full Text] [Related]
19. Occupational Pesticide Exposure in Parkinson's Disease Related to GBA and LRRK2 Variants. Brown EG; Goldman SM; Coffey CS; Siderowf A; Simuni T; Meng C; Brumm MC; Caspell-Garcia C; Marek K; Tanner CM; J Parkinsons Dis; 2024; 14(4):737-746. PubMed ID: 38820021 [TBL] [Abstract][Full Text] [Related]
20. Age at Onset of Parkinson's Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations. Yahalom G; Rigbi A; Israeli-Korn S; Krohn L; Rudakou U; Ruskey JA; Benshimol L; Tsafnat T; Gan-Or Z; Hassin-Baer S; Greenbaum L J Parkinsons Dis; 2020; 10(3):1123-1132. PubMed ID: 32310186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]